A Study of ARRY-438162 in Patients With Rheumatoid Arthritis
NCT00650767
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
201
Enrollment
INDUSTRY
Sponsor class
Conditions
Rheumatoid Arthritis
Interventions
DRUG:
ARRY-438162, MEK inhibitor; oral
DRUG:
Placebo; oral
Sponsor
Array Biopharma, now a wholly owned subsidiary of Pfizer